Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-026159

SrVP/CFO/Prin Fin & Acct Ofcr acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2023-02-27 Grant or award +1,000 $5.25 $5,250 14,493 D
Loading xslF345X03/tm238004-1_4seq1.xml…